Pharmaceuticals, medical device and life science organizations of all sizes have executed digital initiatives at a greater scale in 2020, and continuing through 2021. Marketers do a good job showing how channels reach customers with leading KPIs, but how good a job are we doing demonstrating and actually measuring the impact of digital initiatives on business, especially across channels?
There are many KPIs and channels that can be utilized. However, if senior leadership is not asking the right questions – it becomes increasingly difficult to understand where to make investments or deliver commercial transformation to actually deliver and measure ROI.
Today, there are more questions than answers:
- What are the shortfalls, and are there more strategic analytical roadmaps for success as an industry?
- Is omnichannel driving business impact in a more virtual environment? Does it vary across therapeutic areas and specialties?
- How can we measure/track success as the channel mix changes over time as part of a more advanced attribution model?
- Does ‘digital’ need to be de-siloed and experts redistributed across commercial functions?
- Ultimately, how can the industry look to weather change in digital in this time of flux?
Following the resounding success of the inaugural Re:Imagine Pharma Marketing – at the 2nd Re:Imagine Pharma Marketing, this unique event will provide a detailed view on these crucial supporting elements surrounding launching new digital programs to ensure adoption and excellence in execution from all stakeholders at your organization. Through case studies and planning strategy, you will leave this groundbreaking virtual event with a more holistic internal view of driving innovation that can be applied to any new digital initiative.
REASONS TO ATTEND
✔ Amplify digital at a critical time – identifying what the triggers for ‘must do’ changes, and assessing if these are these connected to true long lasting digital transformation
✔ Examining COVID forced acceptance of Omnichannel marketing importance: where do CX and MCM groups need to channel their energy and what elements to prioritize to deliver a consistent experience of your brand
✔ Analyze content consumption habits and behaviors of HCPs to develop your content and engagement strategy
✔ Scaling video content – keeping the authenticity; examples of good stories that make for great content and pull the story forward to capture emotion
✔ Quantify the right multichannel mix to select the right channel for the corresponding campaign
✔ Optimize your patient journey and adherence as a marketing aid – how ‘how to’ and ‘why’ build as patients continue to increase levels of expectation on access and reach
✔ Build a successful performance measurement framework to better interpret your data and understand your goals within analytics
✔ Minimize data noise and digital health errors through smart use of data analytics and combining data sources
✔ Reimbursement: relocating reimbursement as part of the innovation process – understand the value proposition of tech and quantify the willingness to pay
✔ Evaluate if we have seen the promise of AI come to fruition in this current period of turbulence. Has it done the job that we thought it would?
✔ Develop a methodology of how to split personal and non-personal promotion
WHO SHOULD ATTEND
Managers from the pharmaceutical
Medical Device Industries
Commercial Operations/ Capabilities
Customer Interaction/ Engagement
Advertising and Promotions
Legal Counsel and MLR
THANK YOU TO OUR MEDIA PARTNERS
TAILORED MEDICAL PHARMA INDUSTRY INITIATIVES
The medical pharma marketing industry, to date, has been an underserved community in networks, events and content. At Momentum Health, we are committed to developing not only virtual events – and live events once it is safe to do so – but creating value in non-traditional content creation, network expansion and professional development on a year round basis.
To that end we are developing a Thought Leadership Council to provide a framework for a year round think tank of industry experts across enterprises of all sizes and scale to influence and advance the medical phama/medtech community. This will build a foundation as a vehicle for ideation that is essentially designed by the industry, for the industry.
THOUGHT LEADERSHIP COUNCIL FOR MEDICAL PHARMA
The aim is to create a continuum of information sharing within a community of marketing experts. This will drive ongoing industry dialogue at a time where traditional face to face sales calls and meetings with customers are no longer possible with COVID-19. You can share and evaluate concepts and derive knowledge for yourself and your organization. Even when in-person meetings are safe to attend, we want to cultivate a community of industry experts that are dedicated to improving the state of play for pharma.
Unlike traditional advisory boards, the agenda isn’t driven with a particular event in mind. The value for each individual is in having a safe platform to share the challenges you are facing, the best practices that your peers utilized to overcome challenges, pivots made or just validating general trends you are seeing. Having an expert, peer-led sounding board/think tank that takes place quarterly will help to drive meaningful solutions and processes with real outcomes.
Complimentary Pass Re:Imagine Pharma Marketing(Must be employed by a Pharmaceutical, Biotech, or Medical Device Company to Qualify)
- Interested in meeting with pre-approved Solution Providers offering cutting-edge solutions that can help you Re:Imagine your marketing plans? Apply for a complimentary pass to the Re:Imagine Pharma Marketing Summit in order to receive an all-access pass to the event at no cost.